Skip to content
Corporate & M&A

Going-Private Transactions and MI 61-101 Minority Approval

Going private transactions let insiders acquire a Canadian public company's minority shares, subject to the safeguards in MI 61-101. This guide explains business combinations and insider bids, majority-of-the-minority votes, excluded votes, collateral benefits, formal valuations and the squeeze-out routes available after a bid.

Shareholders voting on going private transactions at a Canadian public company meeting

Key takeaways

  • MI 61-101 adds disclosure, valuation and minority approval safeguards to insider-led deals.
  • Votes of the issuer, interested parties, their related parties and joint actors are excluded.
  • Collateral benefits can be carved out under the 1% ownership or 5% independent committee tests.
  • The valuation listing exemption was updated in September 2025 for the CSE senior tier.
  • After a bid, use s. 206 CBCA at 90% or a second-step under s. 8.2 within 120 days.

How going private transactions work in Canada

Going private transactions are deals in which a controlling shareholder, management group or other insider acquires the shares held by the public, leaving the issuer wholly owned and ultimately delisted. In Canada they are regulated mainly by Multilateral Instrument 61-101 Protection of Minority Security Holders in Special Transactions (MI 61-101), which has been adopted in Ontario, Quebec, Alberta, Manitoba and New Brunswick. MI 61-101 does not prohibit these deals; it adds procedural safeguards so that minority holders are treated fairly: enhanced disclosure, a formal valuation in many cases, and approval by a majority of the minority.

Shareholders voting on going private transactions at a Canadian public company meeting
Going private transactions under MI 61-101 rely on formal valuations, enhanced disclosure and majority-of-the-minority approval.

The instrument uses two main categories for going private transactions. An insider bid is a take-over bid made by an insider of the issuer or its joint actors. A business combination is an amalgamation, arrangement, consolidation or other transaction as a consequence of which a holder's interest in an equity security may be terminated without consent, where a related party is acquiring the issuer, is a party to a connected transaction, or receives a collateral benefit or different consideration. Most friendly going-private deals proceed as business combinations by plan of arrangement.

Majority-of-the-minority approval and excluded votes

Section 4.5 of MI 61-101 prohibits an issuer from carrying out a business combination without minority approval unless an exemption applies. Under s. 8.1, minority approval must be obtained from every class of affected securities, each voting separately, and the issuer must exclude the votes attached to securities held by:

  • the issuer;
  • an interested party (for example, the acquiring controlling shareholder);
  • a related party of an interested party, subject to a limited exception for directors and senior officers of unrelated persons; and
  • a joint actor with an interested party or its related parties in respect of the transaction.

The circular must disclose the number of votes that will be excluded and the holders concerned. In management-led deals, managers who roll equity into the buyer, or who receive collateral benefits, are often interested parties whose votes are excluded. Getting the excluded-vote count right is essential: an error can invalidate the vote or prompt regulatory intervention.

Collateral benefits

A "collateral benefit" is any benefit a related party is entitled to receive as a consequence of the transaction, such as a salary increase, a lump sum payment or enhanced benefits, regardless of offsetting costs. If a related party receives a collateral benefit in a business combination, the transaction may become subject to minority approval and the recipient's votes are excluded.

The definition carves out benefits received solely in connection with services as an employee, director or consultant if the benefit is not conferred to increase the consideration for the related party's shares, is not conditional on supporting the transaction, and is fully disclosed, and if either (a) the related party and its associated entities own less than 1% of each class of equity securities, or (b) in a business combination or bid, an independent committee determines in good faith that the net value of the benefit is less than 5% of the consideration the related party will receive for its shares, and that determination is disclosed. Change-of-control payments and equity acceleration for executives are the usual subjects of this analysis.

Formal valuation requirements and exemptions

Under s. 4.3, an issuer must obtain a formal valuation of the affected securities for a business combination if an interested party would, as a consequence of the transaction, acquire the issuer or its business, or combine with it. The board or an independent committee chooses the valuator and supervises the valuation, and the circular must contain the valuation or a summary. For insider bids, s. 2.3 places the obligation on the offeror, but the independent committee selects and supervises the valuator.

ExemptionSummary
Issuer not listed on specified marketsAvailable if the issuer is not a CSE senior tier issuer and has no securities listed on the TSX, Cboe Canada, the New York Stock Exchange, the American Stock Exchange, Nasdaq or certain foreign exchanges (s. 4.4(1)(a), as amended effective September 2025)
Previous arm's length negotiationsConsideration at least equal to, and in the same form as, the price agreed with arm's length sellers holding a threshold percentage, subject to knowledge and information conditions
AuctionTransaction resulting from a qualifying auction process
Second-step transactionFollows a bid within the prescribed period on the same terms

The amendments published by the CSA in June 2025, described in the CSA notice of publication, updated the exchange list (adding the CSE senior tier and reflecting the Cboe Canada and AQSE Growth Market name changes). Venture issuers listed only on the TSX Venture Exchange, or on the CSE outside its senior tier, can therefore generally rely on the listing exemption from the valuation requirement, but not from minority approval.

Exemptions from minority approval are narrower. They include the situation where interested parties own 90% or more of the class and an appraisal remedy, or an equivalent right, is available (s. 4.6(1)(a)).

Not every conflict transaction is a going-private deal. MI 61-101 also regulates related party transactions, such as an issuer buying assets from, selling assets to or borrowing from a controlling shareholder. These deals do not terminate the minority's interest, but they can transfer value. The instrument generally requires a formal valuation (for certain transaction types) and minority approval, subject to exemptions.

The most frequently used exemptions apply where neither the fair market value of the subject matter nor the fair market value of the consideration, insofar as it involves interested parties, exceeds 25% of the issuer's market capitalization (ss. 5.5(a) and 5.7(1)(a)). Market capitalization is calculated under the instrument's own rules, which refer to the take-over bid instrument's market price provisions. Issuers relying on these exemptions must still disclose the facts supporting reliance in the material change report and, where relevant, the circular.

The distinction matters in practice because a controlling shareholder may sometimes achieve its goals through a series of related party transactions rather than a single business combination. Regulators look at connected transactions together, and a series of steps designed to avoid the protections of the instrument can attract public interest scrutiny.

Squeeze-out routes after a take-over bid

Many going private transactions begin with a take-over bid and end with a second step that removes holders who did not tender. Two main routes exist.

Compulsory acquisition. Under s. 206 of the Canada Business Corporations Act (CBCA), if within 120 days after the date of a take-over bid the bid is accepted by holders of not less than 90% of the shares of the class (other than shares held by the offeror and its affiliates and associates), the offeror may acquire the shares of dissenting offerees on the same terms. Dissenting holders may apply to court to fix fair value. Provincial statutes contain comparable provisions.

Subsequent acquisition transaction. Where the 90% threshold is not met, the offeror can propose a second-step amalgamation or arrangement. Section 8.2 of MI 61-101 allows votes attached to shares acquired under the bid to be counted toward minority approval if, among other conditions, the tendering holders were not joint actors and did not receive collateral benefits or different consideration, the business combination is completed no later than 120 days after expiry of the bid, the consideration is at least equal in value and the same in form as the bid consideration, and the bid circular disclosed the intention to carry out the second step.

Because the mandatory minimum tender under National Instrument 62-104 already requires more than 50% of the shares not held by the bidder, a successful bid often delivers the votes needed for the second step.

Practical point

If the offeror intends to rely on s. 8.2 to count tendered shares in a second-step vote, the bid circular must say so. Plan the second step before launching the bid, including the treatment of any locked-up holders who may be joint actors or receive collateral benefits.

Process, special committees and regulatory review

In going private transactions the controlling shareholder usually holds the bargaining power, so the independence of the target's process matters. A special committee of independent directors is mandatory for insider bids and recommended by regulators for all material conflict transactions. In Multilateral CSA Staff Notice 61-302, staff in Ontario and Quebec described their real-time review of these deals, focusing on disclosure, the availability of exemptions, the exclusion of votes and the board's process.

Corporate law remedies sit alongside MI 61-101. Minority holders may dissent and seek fair value where the statute provides a dissent right (for example, s. 190 CBCA for amalgamations and certain arrangements), oppose the arrangement at the final order hearing, or bring an oppression application. Compliance with MI 61-101 does not prevent those remedies, but a robust process makes them less likely to succeed.

Illustration (hypothetical): A founder holding 45% of a TSX-listed issuer partners with a private equity fund to take the company private by arrangement. The founder will roll his shares into the buyer and receive a new employment agreement. He and the fund are interested parties, so their votes are excluded; a formal valuation is required because an interested party is acquiring the issuer; and the special committee must assess whether other executives' change-of-control payments are collateral benefits. The arrangement needs both the corporate law special resolution and the separate majority-of-the-minority vote.

Typical timeline for going private transactions

  1. Approach by the insider and formation of a special committee with a written mandate.
  2. Engagement of independent legal counsel and an independent valuator.
  3. Negotiation of price and terms, valuation work and fairness opinions.
  4. Signing of the arrangement or support agreement and announcement.
  5. Interim order, circular with MI 61-101 disclosure, and shareholder meeting with separate minority vote.
  6. Final order hearing on fairness, closing, delisting and application to cease to be a reporting issuer.

Regulatory approvals under the Competition Act or Investment Canada Act are rarely an issue where the buyer already controls the issuer, but financing, tax structuring and cross-border securities law questions can affect the timetable.

Cross-border issues deserve early attention. Where the issuer has a significant number of US holders, going private transactions may also engage US tender offer or going-private disclosure rules, and the timetable should allow for any additional filings. Debt financing for the buyer, and any required lender consents under the issuer's existing credit agreements, should be lined up before the circular is mailed so that conditions do not delay closing after the vote.

How TRW & Co helps

We advise controlling shareholders, private equity sponsors, issuers and special committees on going private transactions under MI 61-101: structuring insider bids and business combinations, identifying interested parties and excluded votes, analysing collateral benefits, assessing valuation and minority approval exemptions, and planning compulsory acquisitions and second-step transactions. We work with Canadian counsel where court applications or provincial licences are required. See also public M&A and take-over bids and continuous disclosure, and our insights on special committees and plans of arrangement. To discuss a transaction, contact us.

Frequently asked questions

Which shareholders vote in the majority-of-the-minority vote?

All holders of affected securities except those whose votes must be excluded under s. 8.1 of MI 61-101: the issuer, interested parties, their related parties (with limited exceptions) and joint actors. The circular must disclose the number of excluded votes and the holders concerned.

When is a formal valuation required?

For a business combination, when an interested party would acquire the issuer or its business or combine with it, unless an exemption applies. For an insider bid, the offeror must obtain a formal valuation unless exempt. Exemptions include issuers not listed on specified senior markets and prior arm's length negotiations.

Can shares tendered to a bid be voted in the second step?

Yes, under s. 8.2 of MI 61-101, if conditions are met: tendering holders were not joint actors and got no collateral benefit or different consideration, the second step is completed within 120 days after the bid expires, consideration is at least equal and in the same form, and the bid circular disclosed the plan.

What is the 90% compulsory acquisition right?

Under s. 206 of the CBCA, if a take-over bid is accepted within 120 days by holders of at least 90% of the class (excluding the offeror's and its affiliates' shares), the offeror can acquire the remaining shares on the same terms. Dissenting holders may apply to court to fix fair value.

Sources

  1. Multilateral Instrument 61-101 (OSC unofficial consolidation)
  2. CSA Notice of Publication: amendments including MI 61-101 (19 June 2025)
  3. Canada Business Corporations Act, ss. 190, 206
  4. Multilateral CSA Staff Notice 61-302

General information only, not legal advice. References to statutes, courts and authorities describe published law and practice at the date shown.